Aims: To evaluate potential differences at a molecular level between KRAS mutant tumors (MT) and KRAS wild-type (WT) pancreatic tumors and the biological and prognostic significance of different KRAS mutations. Materials & methods: Expression of a panel of 29 genes was analyzed in KRAS WT and MT tumors. Effects of KRAS mutation and gene expression levels were assessed on patients' survival. Results: MUC6 (p = 0.009), HGF (p = 0.011), VEGFR-2 (p = 0.020) and VEGFB (p = 0.026) were significantly more expressed and SMAD4 was less suppressed (p = 0.003) in WT KRAS. Contrariwise, SHH (p = 0.012) and IHH (p = 0.031) were more expressed in MT KRAS patients. No OS difference was found between WT and MT KRAS tumors. Conclusion: KRAS mutation status seems to identify two different subtypes of pancreatic ductal adenocarcinoma with similar outcome but distinct molecular features and probably different therapeutic targets.
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma / A. Bittoni, F. Piva, M. Santoni, K. Andrikou, A. Conti, C. Loretelli, A. Mandolesi, A. Lanese, C. Pellei, M. Scarpelli, G. Principato, S. Cascinu. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - 11:13(2015 Jul), pp. 1905-1917.
|Titolo:||KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma|
|Parole Chiave:||KRAS; nucleotide variations; overall survival; pancreatic ductal adenocarcinoma; splicing; adenocarcinoma; adult; aged; aged, 80 and over; female; gene expression regulation, neoplastic; humans; male; middle aged; mutation; neoplasm proteins; pancreatic neoplasms; prognosis; proto-oncogene proteins p21(ras); oncology; cancer research; medicine (all)|
|Settore Scientifico Disciplinare:||Settore MED/06 - Oncologia Medica|
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
Settore BIO/13 - Biologia Applicata
Settore MED/04 - Patologia Generale
Settore MED/03 - Genetica Medica
|Data di pubblicazione:||lug-2015|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.2217/fon.15.98|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma.pdf||Publisher's version/PDF||Administrator Richiedi una copia|